Walgreens (NASDAQ:WBA) has reported its April metrics. For the month, the company's sales came in at $5.98 billion, a rise of nearly 4% over the $5.76 billion the company posted in the same month in April 2012. Overall front-end (i.e., non-pharmacy goods) sales fell by 2.9% over that time, while pharmacy sales were 7.3% higher.
Comparable store sales -- a key metric for any retail operation -- advanced 1.2% on a year-over-year basis for the month. Front-end "comps" were down by 4.3% over that time frame, however. Also recording a decline was the metric for customer traffic on a comparable-store basis, which fell 5.9%. Comparable pharmacy sales, on the other hand, grew by 4.7% over April 2012's figure.
Fool contributor Eric Volkman has no position in Walgreens. Nor does The Motley Fool. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.